|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/519 | |
| A61K 39/00 | |||
| A61K 31/505 | |||
| A61K 45/06 | |||
| A61P 29/00 | |||
| C07K 16/24 | |||
| A61K 39/395 |
| (11) | Patento numeris | 2101780 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 07868831.4 |
| Europos patento paraiškos padavimo data | 2007-11-21 | |
| (97) | Europos patento paraiškos paskelbimo data | 2009-09-23 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2013-10-09 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2007/085402 |
| Data | 2007-11-21 |
| (87) | Numeris | WO 2008/064321 |
| Data | 2008-05-29 |
| (30) | Numeris | Data | Šalis |
| 860780 P | 2006-11-21 | US | |
| 902742 P | 2007-02-21 | US |
| (72) |
BEBBINGTON, Christopher R., US
YARRANTON, Geoffrey T., US
|
| (73) |
Kalobios Pharmaceuticals, Inc.,
260 East Grand Avenue, South San Francisco, CA 94080,
US
|
| (54) | METHODS OF TREATING CHRONIC INFLAMMATORY DISEASES USING A GM-CSF ANTAGONIST |
| METHODS OF TREATING CHRONIC INFLAMMATORY DISEASES USING A GM-CSF ANTAGONIST |